Cargando…

Liver Decompensation as Late Complication in HCC Patients with Long-Term Response following Selective Internal Radiation Therapy

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is one of the deadliest forms of cancer. Selective internal radiation therapy (SIRT) is one of the therapeutic options for treatment of advanced HCC. Studies show that SIRT has a high objective response rate, but lack of survival benefit when compared t...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Doorn, Diederick J., Hendriks, Pim, Burgmans, Mark C., Rietbergen, Daphne D. D., Coenraad, Minneke J., van Delden, Otto M., Bennink, Roel J., Labeur, Tim A., Klümpen, Heinz-Josef, Eskens, Ferry A. L. M., Moelker, Adriaan, Vegt, Erik, Sprengers, Dave, Mostafavi, Nahid, Ijzermans, Jan, Takkenberg, R. Bart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582376/ https://www.ncbi.nlm.nih.gov/pubmed/34771591 http://dx.doi.org/10.3390/cancers13215427

Ejemplares similares

Reason of Discontinuation After Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma
por: Labeur, Tim A., et al.
Publicado: (2018)

Study Protocol: Adjuvant Holmium-166 Radioembolization After Radiofrequency Ablation in Early-Stage Hepatocellular Carcinoma Patients—A Dose-Finding Study (HORA EST HCC Trial)
por: Hendriks, Pim, et al.
Publicado: (2022)

Sorafenib for Patients with Hepatocellular Carcinoma and Child‐Pugh B Liver Cirrhosis: Lessons Learned from a Terminated Study
por: Labeur, Tim A., et al.
Publicado: (2019)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: An Overview
por: van Doorn, Diederick J., et al.
Publicado: (2020)

Dose finding study for unilobar radioembolization using holmium-166 microspheres to improve resectability in patients with HCC: the RALLY protocol
por: Andel, Daan, et al.
Publicado: (2023)

Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib
por: Labeur, Tim A., et al.
Publicado: (2019)

Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival
por: Kerbert, Annarein J. C., et al.
Publicado: (2017)

Prognostic value of baseline interleukin 6 levels in liver decompensation and survival in HCC patients undergoing radioembolization
por: Öcal, Osman, et al.
Publicado: (2021)

In Reply: Neoadjuvant TKI Study in Early- and Intermediate Stage Hepatocellular Carcinoma
por: Osanto, Susanne, et al.
Publicado: (2022)

Stereotactic Body Radiation Therapy after Chemotherapy for Unresectable Perihilar Cholangiocarcinoma: The STRONG Trial, a Phase I Safety and Feasibility Study
por: Baak, Rogier, et al.
Publicado: (2021)

Differences in Patient Characteristics and Midterm Outcome Between Asian and European Patients Treated with Radiofrequency Ablation for Hepatocellular Carcinoma
por: Burgmans, Mark Christiaan, et al.
Publicado: (2016)

Monitoring of Total and Regional Liver Function after SIRT
por: Bennink, Roelof J., et al.
Publicado: (2014)

Neoadjuvant Treatment with Angiogenesis‐Inhibitor Dovitinib Prior to Local Therapy in Hepatocellular Carcinoma: A Phase II Study
por: Woei‐A‐Jin, F.J. Sherida H., et al.
Publicado: (2021)

Multiparametric MRI in Patients With Nonalcoholic Fatty Liver Disease
por: Schaapman, Jelte J., et al.
Publicado: (2020)

Study Protocol PROMETHEUS: Prospective Multicenter Study to Evaluate the Correlation Between Safety Margin and Local Recurrence After Thermal Ablation Using Image Co-registration in Patients with Hepatocellular Carcinoma
por: Oosterveer, Timo T. M., et al.
Publicado: (2022)

Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial)
por: de Wit, K, et al.
Publicado: (2020)

Chemoprevention in Patients with Peutz‐Jeghers Syndrome: Lessons Learned
por: de Brabander, Justin, et al.
Publicado: (2018)

Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial
por: Seidensticker, Max, et al.
Publicado: (2023)

Variable efficacy of TIPSS in the management of ectopic variceal bleeding: a multicentre retrospective study
por: Oey, Rosalie C., et al.
Publicado: (2018)

Hepatocellular adenoma: when and how to treat? Update of current evidence
por: Thomeer, Maarten G., et al.
Publicado: (2016)

Risk Factors for Liver Decompensation and HCC in HCV-Cirrhotic Patients after DAAs: A Multicenter Prospective Study
por: Morisco, Filomena, et al.
Publicado: (2021)

Fully automated AI-based splenic segmentation for predicting survival and estimating the risk of hepatic decompensation in TACE patients with HCC
por: Müller, Lukas, et al.
Publicado: (2022)

Nationwide treatment and outcomes of perihilar cholangiocarcinoma
por: van Keulen, Anne‐Marleen, et al.
Publicado: (2021)

Towards new treatment options for renal cell carcinoma: development and clinical results of tivozanib, a selective VEGFR tyrosine kinase inhibitor
por: Eskens, Ferry ALM, et al.
Publicado: (2012)

Development and validation of a dynamic survival prediction model for patients with acute-on-chronic liver failure
por: Goudsmit, Ben F.J., et al.
Publicado: (2021)

Efficacy and safety of FOLFIRINOX as salvage treatment in advanced biliary tract cancer: an open-label, single arm, phase 2 trial
por: Belkouz, Ali, et al.
Publicado: (2020)

Quantitative Volumetric Assessment of Ablative Margins in Hepatocellular Carcinoma: Predicting Local Tumor Progression Using Nonrigid Registration Software
por: Hendriks, P., et al.
Publicado: (2019)

Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis
por: Trebicka, Jonel, et al.
Publicado: (2019)

The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets
por: van Riet, Job, et al.
Publicado: (2021)

Protocol for the STRONG trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma, a phase I feasibility study
por: Koedijk, Merel S, et al.
Publicado: (2018)

The Treatment Effect of Liver Transplantation versus Liver Resection for HCC: A Review and Future Perspectives
por: Beumer, Berend R., et al.
Publicado: (2021)

Spinal decompensation in degenerative lumbar scoliosis
por: de Vries, A. A. Benjamin, et al.
Publicado: (2010)

Local but not systemic administration of mesenchymal stromal cells ameliorates fibrogenesis in regenerating livers
por: van der Helm, Danny, et al.
Publicado: (2019)

Oncofetal Protein CRIPTO Is Involved in Wound Healing and Fibrogenesis in the Regenerating Liver and Is Associated with the Initial Stages of Cardiac Fibrosis
por: Karkampouna, Sofia, et al.
Publicado: (2021)

Camrelizumab—targeting a novel PD-1 epitope to treat hepatocellular carcinoma
por: Rakké, Yannick Sebastiaan, et al.
Publicado: (2020)

Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis
por: Kerbert, Annarein J. C., et al.
Publicado: (2015)

Genetic variants of innate immunity receptors are associated with mortality in cirrhotic patients with bacterial infection
por: Schaapman, Jelte J., et al.
Publicado: (2020)

FOLFIRINOX and radiotherapy for locally advanced pancreatic cancer: A cohort study
por: Suker, Mustafa, et al.
Publicado: (2018)

HCC, diet and metabolic factors: Diet and HCC
por: Montella, Maurizio, et al.
Publicado: (2011)

First-line treatment with oxaliplatin and capecitabine in patients with advanced or metastatic oesophageal cancer: a phase II study
por: van Meerten, E, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_1eamojnv7t8o51lcij6e153qdn